Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Details Narrative)

v3.5.0.2
Stockholders' Deficiency (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 18, 2016
Apr. 08, 2016
Mar. 24, 2016
Mar. 11, 2016
Jul. 28, 2015
Aug. 07, 2014
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Jun. 24, 2016
Jan. 31, 2016
Stock based compensation             $ 280,792     $ 1,102,606 $ 842,038 $ 2,862,840      
Cash payment of settlement $ 172,645 $ 178,893     $ 737,425 $ 112,500                  
Number of warrants issued to purchase of common stock shares                             1,290,000
Warrants exercise price per share                           $ 0.70 $ 2.25
Unrecognized stock based compensation expense related to stock option             $ 196,537       $ 196,537        
Unrecognized stock option weighted average remaining vesting period                     10 months 24 days        
Weighted average fair value of option granted             $ 0.51     $ 0.37 $ 0.38 $ 0.37      
Warrant modification expense                     $ 457        
Issued shares exchange for cash                     $ (45,000)        
Number of fully vested common stock shares issued             348,081       348,081        
Stock issued for compensation                     $ 382,789        
Fair value shares granted date                     $ 65,982        
Warrants [Member]                              
Number of warrants issued to purchase of common stock shares             25,000       25,000        
Warrants exercise price per share                           $ 0.70  
Former Members [Member]                              
Number of shares returned to former members               242,303              
Issued shares exchange for cash               $ 45,000              
Chief Operating Officer [Member]                              
Fair value of issue shares                     $ 300,000        
Stock based compensation             $ 0       $ 68,852        
Number of shares issued during period                     750,000        
Board of Directors [Member]                              
Stock based compensation                     $ 35,924   $ 30,058    
Board of Directors [Member] | 2016 Meetings [Member]                              
Stock issued for compensation                     194,158        
Board of Directors [Member] | 2015 Meetings [Member]                              
Stock issued for compensation                     153,923        
Purchaser [Member] | Securities Purchase Agreements [Member]                              
Net proceeds from issuance costs       $ 85,285                      
Gross proceeds from issuance costs       99,960                      
Issuance costs       14,675                      
Accrued expenses             $ 9,677       $ 9,677        
Number of warrants issued to purchase of common stock shares             3,017,047       3,017,047        
Warrants exercise price per share             $ 1.00       $ 1.00        
Derivative liabilities             $ 167,956       $ 167,956        
Series A Convertible Preferred Stock [Member]                              
Preferred stock shares issued     500,000       11,000,000   10,500,000   11,000,000   10,500,000    
Fair value of issue shares     $ 500,000                        
Stock based compensation             $ 0       $ 114,754        
Series B Convertible Preferred Stock [Member]                              
Preferred stock shares issued             8,250   8,250   8,250   8,250    
Preferred stock liquidation preference             $ 825,000       $ 825,000        
Series C Convertible Preferred Stock [Member]                              
Preferred stock shares issued             150,426   120,330   150,426   120,330    
Fair value of issue shares     $ 75,000                        
Stock based compensation             $ 0       $ 17,213        
Preferred stock liquidation preference             15,407,900       15,407,900        
Preferred stock aggregate subscription amount       2,900,040                      
Cash payment of settlement       650,040                      
Remaining amount       $ 2,250,000                      
Net proceeds from issuance costs             1,147,950       1,147,950        
Gross proceeds from issuance costs             1,267,160       1,267,160        
Issuance costs             197,160       197,160        
Accrued expenses             149,658       149,658        
Convertible preferred shares       21,120                      
Number of warrants issued to purchase of common stock shares       238,000                      
Warrants exercise price per share       $ 1.00                      
Derivative liabilities       $ 10,458                      
Number of preferred stock shares issued in satisfaction of liability       1,666                      
Number of shares issued during period     750         318,400 2,932            
Payment of dividends             $ 365,300 $ 3,184 $ 293,200            
Series C Convertible Preferred Stock [Member] | Board of Directors [Member]                              
Fair value of issue shares                     $ 39,964        
Number of shares issued during period                     444